ViaDerma in The Press

ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product

The Company unveils brand name for its planned minoxidil hair regrowth productLOS ANGELES, March 16, […]

LOS ANGELES, March 08, 2023 (Benzinga) – ViaDerma, Inc. (OTC: VDRM) is pleased to announce […]

The Company has expanded its current wound care licensing agreement to 11 states and expects […]

ViaDerma, Inc. (OTC Pink: VDRM) is extremely pleased to announce that they have retained the […]

LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) ViaDerma, Inc., (OTC Pink: VDRM) announces the successful […]

LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) — ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces […]

LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) — ViaDerma, Inc., (OTC Pink: VDRM) is pleased […]

LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) ViaDerma, Inc., (OTC Pink: VDRM) published a Quarterly […]

LOS ANGELES, Aug. 27, 2020 (GLOBE NEWSWIRE) ViaDerma, Inc., (OTC Pink:VDRM), is pleased to provide […]

LOS ANGELES, CA (Yahoo! Finance – February 03, 2017) – ViaDerma, Inc. (OTC PINK: VDRM), a […]

LOS ANGELES, Dec. 9, 2014 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC:VDRM), a specialty pharmaceutical company devoted to […]